Surgical Therapy for Perihilar Cholangiocarcinoma: State of the Art

Background: Surgical therapy still offers the only chance of long-term survival for patients with perihilar cholangiocarcinoma (pCCA). The aim of this narrative review is to summarize the current standards and challenges in the surgical treatment of pCCA. Summary: After imaging and defining resectability, the first step towards optimal surgical treatment is optimizing biliary drainage and preventing cholangitis, followed by securing adequate future liver remnant volume and/or function. The main goal of resection for pCCA is achieving radical resection and ultimately long-term survival. In order to achieve radical resection, several points will be addressed (e.g., vascular resection and reconstruction, intraoperative frozen sections, right versus left hemihepatectomy, and the usefulness of preoperative [chemo]therapy). Key Messages: In order to optimize long-term outcomes for patients with pCCA, collaboration between leading centers should be increased. In addition, this collaboration is necessary to design large prospective randomized controlled trials, as the incidence of pCCA is low and the number of resectable patients is even lower. Currently, most results are based on small retrospective cohort studies resulting in low evidence. In order to properly investigate how to improve long-term survival, we need to set up trials to confirm the results of small series suggesting the positive effect of preoperative chemotherapy and extended lymph node resection. (c) 2021 The Author(s) Published by S. Karger AG, Basel

Automated summary

Collaboration between leading centers is crucial to optimize long-term outcomes for patients with pCCA. Large prospective randomized controlled trials are needed due to the low incidence of pCCA and limited number of resectable patients. Current evidence is based on small retrospective cohort studies, and trials are necessary to confirm the positive effects of preoperative chemotherapy and extended lymph node resection for improving long-term survival.